NΞws
Rare diseases! not so rare…APTEEUS is starting two new projects
APTEEUS is currently starting two new challenges aimed at repositioning drugs for children suffering from…
Identification of an experimental treatment for Noé
Already implemented for several patients, Apteeus’ technology has just identified a drug that could improve…
Project manager position
APTEEUS is seeking a new collaborator to manage new projects of individualized drug discovery. See…
RARE DISEASE DAY
We are not patients, we are not families, we are not doctors…but we live with…
APTEEUS, European Venture Contest Finalist
APTEEUS has been awarded at the France Tech Transfer Invest 2019. France Tech Transfer Invest…
We can’t wait for 2019
Apteeus has started a tailor-made research program for the association Les Petits Mec P2. Less…
APTEEUS will attend the European Conference on Rare Diseases and Orphan Products in Vienne
Rare Disease 360°, Collaborative Strategies to leave no-one behind Proud to present the high potential…
HAPPY NEW YEAR !
Camille, Isabelle, Loïc, Simon, Benoit and Terence wish you all the best for 2018.
The first edition of Hibster
The first edition of Hibster is 120 brains in turmoil, 48h of thinking for unlimited…
APTEEUS, Laureate of the Concours Mondial de l’Innovation 2030
This is thanks to an innovative strategy of Individualized Medicine, that the pair of Pharmacists,…
Lille Metropole Innovation
December 4, 2014, Benoit and Terence presented APTEΞUS activity to the LMI committee (Lille Metropole Innovation).…
Biotech Finances
APTEEUS pushes the boundaries of personalized medicine.